ARTICLE | Company News
Bristol-Myers, Pfizer cardiovascular news
August 24, 2015 7:00 AM UTC
Hedge fund manager Kyle Bass is challenging a patent on Eliquis apixaban from Bristol-Myers and Pfizer with an inter partes review (IPR) petition. The Coalition for Affordable Drugs IX, an entity ass...